John Maher (J Maher)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

Biology

Expert review of clinical immunology

Cancers

Cells

Eastbourne District General Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Eastbourne District General Hospital Oct 01 2016

United Kingdom

Consultant in Immunology

Publications

Chelsea Alice Taylor, Maya Glover, John Maher
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours. Expert review of clinical immunology 20 (8) (2024)
David M Davies, Giuseppe Pugliese, Ana C Parente Pereira, Lynsey M Whilding, Daniel Larcombe-Young, John Maher
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy. Biology 13 (3) (2024)
David M Davies, Giuseppe Pugliese, Ana C Parente Pereira, Lynsey M Whilding, Daniel Larcombe-Young, John Maher
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy. Biology 13 (3) (2024)
Chelsea Alice Taylor, Maya Glover, John Maher
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours. Expert review of clinical immunology 20 (8) (2024)
David M Davies, Giuseppe Pugliese, Ana C Parente Pereira, Lynsey M Whilding, Daniel Larcombe-Young, John Maher
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy. Biology 13 (3) (2024)
Chelsea Alice Taylor, Maya Glover, John Maher
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours. Expert review of clinical immunology (2024)
John Maher, David M Davies
CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens. Biology 12 (2) (2023)
John Maher, David M Davies
CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. Cancers 15 (4) (2023)
John Maher, David M Davies
CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. Cancers 15 (4) (2023)
John Maher, David M Davies
CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens. Biology 12 (2) (2023)
Sophie Papa, Antonella Adami, Michael Metoudi, Richard Beatson, Molly Sarah George, Daniela Achkova, Evangelia Williams, Sefina Arif, Fiona Reid, Maria Elstad, Nicholas Beckley-Hoelscher, Abdel Douri, Marc Delord, Mike Lyne, Dharshene Shivapatham, Christopher Fisher, Andrew Hope, Sakina Gooljar, Arindam Mitra, Linda Gomm, Cienne Morton, Rhonda Henley-Smith, Selvam Thavaraj, Alice Santambrogio, Cynthia Lilian Andoniadou, Sarah Allen, Victoria Gibson, Gary J R Cook, Ana C Parente-Pereira, David M Davies, Farzin Farzaneh, Anna Schurich, Teresa Guerrero-Urbano, Jean-Pierre Jeannon, James Spicer, John Maher
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study. Journal for immunotherapy of cancer 11 (6) (2023)
Alberto Gabizon, Hilary Shmeeda, Benjamin Draper, Ana Parente-Pereira, John Maher, Amaia Carrascal-Miniño, Rafael T M de Rosales, Ninh M La-Beck
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes. Pharmaceutics 15 (11) (2023)
John Maher, David M Davies
CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. Cancers 15 (4) (2023)
John Maher
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives. OncoTargets and therapy 16 (2023)
Ge Tan, Katelyn M Spillane, John Maher
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer. Biology 12 (8) (2023)
John Maher, David M Davies
CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens. Biology 12 (2) (2023)
Daniela Yordanova Achkova, Richard Esmond Beatson, John Maher
CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor Receptor. Cells 11 (14) (2022)
Caroline M Hull, John Maher
3D modelling of γδ T-cell immunotherapy. Clinical and translational medicine 12 (5) (2022)
Roberta Mazza, John Maher
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies. Archivum immunologiae et therapiae experimentalis 70 (1) (2021)
Antonella Adami, John Maher
An overview of CAR T-cell clinical trial activity to 2021. Immunotherapy advances 1 (1) (2021)
May C I van Schalkwyk, Sjoukje J C van der Stegen, Leticia Bosshard-Carter, Helen Graves, Sophie Papa, Ana C Parente-Pereira, Farzin Farzaneh, Christopher D Fisher, Andrew Hope, Antonella Adami, John Maher
Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells. Cells 10 (7) (2021)
John Wahba, Marina Natoli, Lynsey M Whilding, Ana C Parente-Pereira, Youngrock Jung, Stefania Zona, Eric Wing-Fai Lam, J Richard Smith, John Maher, Sadaf Ghaem-Maghami
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer. Cancer immunology, immunotherapy : CII 67 (11) (2018)
Mustafa Yassin Taher, David Marc Davies, John Maher
The role of the interleukin (IL)-6/IL-6 receptor axis in cancer. Biochemical Society transactions 46 (6) (2018)
D J Mac Lochlainn, R Hira-Kazal, H Varney, John Maher
Implementation of National Institute for Health and Care Excellence (NICE) guidance to measure immunoglobulin A with all coeliac screens: can an affordable solution be devised? Clinical and experimental immunology 189 (3) (2017)

John Maher.css-eqlu8i{font-size:small;padding-left:4px;} (J Maher)

Publication Activity (10 Years)

Top Topics

Top Venues

John Maher (J Maher)